BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Built with biopharmaceutical industry insights\, this in-perso
 n conference will bring together key opinion leaders from Europe and the 
 rest of the world to delve deep into the challenges associated with succe
 ssfully designing and developing the next-generation of mRNA-based vaccin
 es &amp\; therapeutics with improved specificity\, delivery &amp\; effica
 cy for immuno-oncology\, infectious diseases and beyond.\n\nWith 20+ pion
 eering large pharma\, biotech and academic experts who are shaping the la
 ndscape of mRNA- based therapeutics for the scientific community world-wi
 de\, hear how they address the major challenges facing the industry.\n\nO
 ptimise the Efficacy\, Cell- &amp\; Tissue- Specificity &amp\; Translatab
 ility of Your mRNA- Based PipelineWith the limitless opportunity of mRNA-
  based Therapeutics across different modalities\, consider the challenges
  of efficacy and improve cell- &amp\; tissue- specificity with expert ins
 ights from Professor Drew Weissman\, Strand Therapeutics &amp\; Chalmers 
 University of Technology\n\nExplore Applications of mRNA- Based Therapeut
 ics Beyond Infectious DiseasesFrom immune-oncology to rare and autoimmune
  diseases\, dive into emerging applications and potential challenges of m
 RNA- based vaccines and therapeutics beyond infectious diseases with case
  studies from Moderna\, BioNTech &amp\; Ethris\n\nNavigate New &amp\; Eme
 rging Delivery Technologies for mRNA- Based TherapeuticsTake yourself to 
 the forefront of mRNA delivery system development\, from structure throug
 h to administration with insights from BioNTech\, Johnson &amp\; Johnson 
 &amp\; Med Therapeutics\n\nStrategise Your Scalable &amp\; Global mRNA-Ba
 sed Vaccine DevelopmentWith the global outreach of mRNA- based vaccines\,
  scalability is a major hurdle. Hear the latest technological advances an
 d regulatory standards in mRNA- based vaccine and therapeutic landscape f
 rom Sanofi\, Ziphius Vaccines &amp\; Arcturus Therapeutics\n\nTune into H
 ow Companies are Differentiating Their Pipelines Beyond mRNA- Based Vacci
 nesWith the success of mRNA- based vaccines fulfilling novel technologies
  and therapies such as mRNA- based protein replacement\, hear from compan
 ies like Strand Therapeutics\, Turn Biotechnologies &amp\; Orna Therapeut
 ics on the emerging strategies that will enable innovation in the field\n
 \nTake advantage of our group discounts\, academic rates and earlybird sa
 vings - don't miss out register now for the best rate!\n
DTEND:20220127T160000
DTSTAMP:20260416T141937Z
DTSTART:20220125T083000
LOCATION:Hotel NH Collection Berlin Friedrichstrasse\, 96 Friedrichstraße\
 , Berlin\, Berlin\, 10117\,
SEQUENCE:0
SUMMARY:Built with biopharmaceutical industry insights\, this in-person co
 nference will bring together key opinion leaders from Europe and the rest
  of the w...
UID:e7f4fcc9-774a-4327-8d65-c216768f7593
END:VEVENT
END:VCALENDAR